Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
The World Needs New Antibiotics, but the Business Model Is Broken
Business

The World Needs New Antibiotics, but the Business Model Is Broken

New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
Business

Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges

The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link

Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
Business

Drug Shortages Are a Boon to One Industry: Compounding Pharmacies

Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link

Pfizer’s Covid Boost Crashes to Earth
Business

Pfizer’s Covid Boost Crashes to Earth

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.

First Pill for Postpartum Depression Is Approved by FDA
Business

First Pill for Postpartum Depression Is Approved by FDA

The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link

FDA Approves First RSV Drug to Protect All Infants
Business

FDA Approves First RSV Drug to Protect All Infants

While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link

FDA Approves First Over-the-Counter Birth-Control Pill
Business

FDA Approves First Over-the-Counter Birth-Control Pill

The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S.   Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Business

FDA's OK Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

FDA Approval Isn't Always a Happy Day for Biotech Investors
Finances

FDA Approval Isn't Always a Happy Day for Biotech Investors

In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link

FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Business

FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients

Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link